Eledon Pharmaceuticals
ELDN
ELDN
11 hedge funds and large institutions have $12.5M invested in Eledon Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
11
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$696K | |
| 2 | +$51K | |
| 3 | +$38.2K | |
| 4 |
BlackRock
New York
|
+$1.55K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.02K |
Top Sellers
| 1 | -$53K | |
| 2 | -$16.2K | |
| 3 | -$6.12K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1K |